Results 121 to 130 of about 20,805 (196)

Plasmacytic markers as immunotherapeutic targets for primary CD20-negative aggressive B-cell lymphomas. [PDF]

Br J Haematol
Neumann F, Schormann C, Cetin O, Kos IA, Bewarder M, Schwarz EC, Lohse S, Maurer S, Staber PB, Bittenbring JT, Smola S, Christofyllakis K, Hoth M, Thurner L.   +13 more
europepmc   +1 more source

Functional antibody responses and protection against symptomatic dengue. [PDF]

Commun Med (Lond)
Chua CLL, Vo HTM, Victorio CBL, Upasani V, Yap BJM, Teo A.   +5 more
europepmc   +1 more source

IMGT-NC Engineered Variants of INN Therapeutic IG or Antibodies and Related IgSF Proteins (TR, FPIA and CPCA): Bridging Sequences, Structures and Functions for AI. [PDF]

Biomolecules
Lefranc MP.
europepmc   +1 more source

Dual Antiviral Functions of Antibodies Targeting African Swine Fever Virus p17 Protein: Viral Inhibition and ADCC Induction. [PDF]

Viruses
Chen S, Jiang C, Lu Z, Lan J, Fu Q, Sun Y, Wang T, Qiu HJ.   +7 more
europepmc   +1 more source

Fc-Silenced CD89 × EGFR Bispecific Antibodies Promote Neutrophil and Macrophage Antitumor Activity. [PDF]

Antibodies (Basel)
Meiser F, Harwardt J, Hahn C, Lustig M, Valerius T, Kolmar H.   +5 more
europepmc   +1 more source

Longitudinal assessment of functional antibodies to a novel influenza virus strain across age groups. [PDF]

PLoS Pathog
Huckriede A, Hoorn I, Joshi M, de Vries-Idema J, Vidarsson G, van Kasteren PB, Beukema M.   +6 more
europepmc   +1 more source

Bispecific antibody AP402 targets p95HER2 and induces costimulation through CD137 to improve efficacy for HER2-positive tumors. [PDF]

Mol Med
Huang PL, Hsieh HT, Kan HT, Hsu CH, Huang KM, Chen HY, Chen TN, You JJ.   +7 more
europepmc   +1 more source

Cancer cell-selective ectopic expression of CD20 as an antigen enables rituximab repurposing for solid tumour immunotherapy. [PDF]

Clin Transl Med
Kong Z, Wang Y, Zhao Y, Wang L, Fan Z, Shu Y, Wang J.   +6 more
europepmc   +1 more source

Antibody-Based Therapeutics in Autoimmune Diseases: Mechanisms, Challenges, and Future Perspectives. [PDF]

Int J Mol Sci
Mahroum N.
europepmc   +1 more source